Serotonin-induced reduction of the calcium-dependent plateau in frog dorsal root ganglion cells is blocked by serotonergic agents acting at 5-hydroxytryptamine1A sites
- PMID: 2972829
Serotonin-induced reduction of the calcium-dependent plateau in frog dorsal root ganglion cells is blocked by serotonergic agents acting at 5-hydroxytryptamine1A sites
Abstract
Intracellular recordings from the dorsal root ganglion cells of adult frogs in the presence of tetraethylammonium display action potentials with a prominent calcium-dependent plateau. These action potentials can be altered by serotonergic agents in one of two ways. The superfusion of 5-HT (0.1-1 microM) usually produces a dose-dependent reduction of the action potential duration, whereas 8-hydroxy dipropylaminotetralin (8-OH-DPAT) (10-50 microM) produces a dose-dependent increase in duration. A series of 5-HT antagonists were tested for their ability to block either the 5-HT or the 8-OH-DPAT effect. The antagonists were chosen for their reported selectivity in distinguishing receptors of the 5-HT1A, 5-HT2 and 5-HT3 subtypes. The antagonists' action on 5-HT narrowing [blockade by methiothepin, spiperone and spiroxitrine, but not by ketanserin or 3-tropyl-indole-3-carboxylate (ICS 205-930)] suggests that this response is mediated by 5-HT1A receptors. The widening effect produced by 8-OH-DPAT (a putative 5-HT1A agonist) was not blocked by any antagonist tested. At lower concentrations (0.1-2.5 microM) 8-OH-DPAT exhibited no agonist actions, but antagonized the 5-HT-induced narrowing. These results suggest the 5-HT receptors mediating 5-HT action potential narrowing in these cells are of the 5-HT1A subtype, but that they differ from the 5-HT1A receptors described in other tissues in which 8-OH-DPAT is an agonist or a partial agonist.
Similar articles
-
Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.J Pharmacol Exp Ther. 1994 Sep;270(3):1345-58. J Pharmacol Exp Ther. 1994. PMID: 7932189
-
5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.J Pharmacol Exp Ther. 1991 Mar;256(3):983-92. J Pharmacol Exp Ther. 1991. PMID: 1672380
-
Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.J Pharmacol Exp Ther. 1994 Jan;268(1):337-52. J Pharmacol Exp Ther. 1994. PMID: 8301575
-
5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.J Pharmacol Exp Ther. 1993 Jan;264(1):95-104. J Pharmacol Exp Ther. 1993. PMID: 8423555
-
Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.Am J Cardiol. 1989 Aug 15;64(7):7D-10D. doi: 10.1016/0002-9149(89)90688-7. Am J Cardiol. 1989. PMID: 2569265 Review.
Cited by
-
Endogenous monoamines inhibit glutamate transmission in the spinal trigeminal nucleus of the guinea-pig.J Physiol. 1996 Feb 15;491 ( Pt 1)(Pt 1):177-85. doi: 10.1113/jphysiol.1996.sp021205. J Physiol. 1996. PMID: 9011609 Free PMC article.